Login
$TVRD
$0.87 +$0.02 (2.76%) Close

$TVRD 4 SEC Filings

Filed On Filing
11 Jun 2026 Form 4: Shiff Susan Ph.D., Director

Granted 6,000 Stock Option (right to buy)

11 Jun 2026 Form 4: Smith Cynthia, Director

Granted 6,000 Stock Option (right to buy)

11 Jun 2026 Form 4: Shah Sujal, Director

Granted 6,000 Stock Option (right to buy)

11 Jun 2026 Form 4: Hall Wallace L Jr, Director

Granted 6,000 Stock Option (right to buy)

11 Jun 2026 Form 4: Wyzga Michael S, Director

Granted 6,000 Stock Option (right to buy)

02 Feb 2026 Form 4: O'Brien Stephen Paul, Principal Accounting Officer

Granted 15,000 Employee Stock Option (right to buy)

02 Feb 2026 Form 4: Conn Avi Daniel, Chief Financial Officer

Granted 45,000 Employee Stock Option (right to buy)

02 Feb 2026 Form 4: Alibhai Imran Nizamudin, Director

Granted 115,000 Employee Stock Option (right to buy)

02 Feb 2026 Form 4: Kauh John Saewook M.d., Chief Medical Officer

Granted 45,000 Employee Stock Option (right to buy)

18 Dec 2025 Form 4: O'Brien Stephen Paul, Principal Accounting Officer

Granted 4,000 Employee Stock Option (right to buy)

18 Dec 2025 Form 4: Kauh John Saewook M.d., Chief Medical Officer

Granted 17,500 Employee Stock Option (right to buy)

18 Dec 2025 Form 4: Conn Avi Daniel, Chief Financial Officer

Granted 17,500 Employee Stock Option (right to buy)

18 Dec 2025 Form 4: Alibhai Imran Nizamudin, Director

Granted 47,500 Employee Stock Option (right to buy)

05 Aug 2025 Form 4: Tweardy Samuel David, 10% owner

Disposed of 631,316 shares (Other Transaction)

21 Apr 2025 Form 4: Larson Jeffrey Leroy, SVP, Research & Development

Granted 10,820 Employee Stock Option (right to buy)

21 Apr 2025 Form 4: O'Brien Stephen Paul, Principal Accounting Officer

Granted 7,213 Employee Stock Option (right to buy)

21 Apr 2025 Form 4: Chen Yixin, VP, Chem, Mfg and Ctrls

Granted 7,213 Employee Stock Option (right to buy)

21 Apr 2025 Form 4: Conn Avi Daniel, Chief Financial Officer

Granted 43,547 Employee Stock Option (right to buy)

21 Apr 2025 Form 4: Kauh John Saewook M.d., Chief Medical Officer

Granted 36,210 Employee Stock Option (right to buy)

21 Apr 2025 Form 4: Alibhai Imran Nizamudin, Director

Granted 182,320 Employee Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support